期刊文献+

连续性血液净化治疗难治性心力衰竭 被引量:2

CONTINUOUS BLOOD PURIFICATION IN THE TREATMENT OF REFRACTORY CONGESTIVE HEART FAILURE
下载PDF
导出
摘要 目的观察连续性血液净化(continuous blood purification,CBP)技术治疗难治性心力衰竭患者的临床疗效。方法采用美国 Baxter BM25 床旁血滤机,Fresenius Polysulfone AV600S 血滤器。置换液采用南京军区总院配方,置换液流量2~3 L/h。前稀释法,血流量150~220 mL/min,低分子肝素首剂15~20 U/kg 静脉注射抗凝,此后追加7.5~10.0U/kg·h^(-1)。24 h 连续治疗,持续2~10d。连续治疗8 h 更换血滤器、血滤管路。同时针对原发病给予病因治疗,患者病情好转,改为 CBP 6~12 h/d,再改为药物治疗。结果 15例患者显效11例,有效3例,无效1例,总有效率93.3%。结论 CBP 技术治疗难治性心力衰竭患者临床症状改善明显,不良反应发生率低。 Objective To evaluate the clinical value of continuous blood purification(CBP) technique in the treatment of refractory congestive heart failure. Methods Continuous bedside hemofihration was performed with Baxter BM25 with a polysulfone AV 600S membrane in 15 patients with refractory congestive heart failure. The composition of substitution fluid is according to the formula of Nanjing PLA General Hospital, with a substitution volume of 2 ~ 3 L/h. The treatment pattern adopted is anterior dilution method,the blood volume is 150-220 mL/min. To use low molecular heparin with first dosage of 15-20 U/kg ivgtt to anticoagulate,later add 7.5- 10 U/kg·h^-1 more and undergo for 24 h continuous treatment and lasting for 2-10 d. After 8 h continuous treatment then change membrane of hemofilter used in CBP and hemofiltration access. Meanwhile treat the cause of disease according to the primary disease. If the condition of disease is improved,then use CBP for 6~12 h and change for drug treatment. Results Of 15 patients ,11 of them are obviously effective, 3 are effective, one is of non-effecive. The general rate of effectiveness is 93.3 %. Conclusion CBP technique can obviously improve the clinical symptoms of congestive heart failure and with low rate of oecurence of side effects.
出处 《河北医科大学学报》 CAS 2009年第4期334-335,共2页 Journal of Hebei Medical University
关键词 肾透析 心力衰竭 充血性 治疗 renal dialysis heart failure, congestive therapy
  • 相关文献

参考文献4

二级参考文献8

  • 1廖履坦.多系统脏器衰竭[A].见:陈灏珠 主编.实用内科学 第 10版[C].北京:人民卫生出版社,1997.1750-1755.
  • 2Bertand LJ, Brian JGP. Inflammatory mediatoris in sepsis: rational for extracorporeal therapies?AM J Kidney Dis, 1996, 28(1): 35
  • 3Garcia- Fernandez N, Lavilla FJ, Rocha E, et al. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy. J Nephrol, 2000, 13(4): 282-289
  • 4Ronco C,Tetta C,Mariano F. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs, 2003, 27(9): 792-801
  • 5Lowrie LH. Renal replacement therapies in pediatric multiorgan dysfunction syndrome. Pediatr Nephrol, 2000, 14(1): 6-12
  • 6Lonnemann G, Floege J, Kliem V, et al.Extended daily veno- venous high- flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a single path batch dialysis system. Nephrol Dial Transplant, 2000, 15(8): 1189-1193
  • 7Consensus recommendations for the management of chronic heart failure.On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure[].The American Journal of Cardiology.1999
  • 8丁小强,叶志斌,蔡金根,廖履坦,徐元钊,吴兆龙,陶凤武.连续肾脏替代疗法治疗急性肾功能衰竭伴多脏器衰竭[J].中华肾脏病杂志,1998,14(5):307-310. 被引量:41

共引文献2892

同被引文献11

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部